Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Repare Therapeutics Inc (NQ: RPTX )

3.315 -0.095 (-2.79%)
Streaming Delayed Price Updated: 11:50 AM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Repare Therapeutics Inc

< Previous 1 2 3 Next >
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Recap: Repare Therapeutics Q4 Earnings
Via Benzinga
Recap: Repare Therapeutics Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're diving into the biggest pre-market stock movers for Wednesday will a look at all of the latest news happening this morning. 
Via InvestorPlace
RPTX Stock Earnings: Repare Therapeutics Beats EPS, Beats Revenue for Q1 2024
RPTX stock results show that Repare Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + GemOx vs. Rituxan + GemOx. 
Via Benzinga
Wall Street Thinks This Cathie Wood Stock Could Jump by 187%
This small-cap biotech stock holds enormous growth potential. 
Via The Motley Fool
Analyst Expectations for Repare Therapeutics's Future
Via Benzinga
Recap: Repare Therapeutics Q1 Earnings
Via Benzinga
Analyst Expectations for Repare Therapeutics's Future
Via Benzinga
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved. 
Via Benzinga
These Biotech Stocks Could Double Your Money, According To Analysts
Via Benzinga
$2.8M Bet On Repare Therapeutics? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
4 Analysts Have This to Say About Repare Therapeutics
Via Benzinga
Repare Therapeutics's Return On Capital Employed Insights
Via Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2023
Via Benzinga
Repare Therapeutics Releases Early Anticancer Activity From Its Monotherapy, Combination Trials
Repare Therapeutics Inc (NASDAQ: RPTX) reported initial proof of concept monotherapy data from its Phase 1 MYTHIC trial evaluating lunresertib (RP-6306) in molecularly selected  
Via Benzinga
Cathie Wood Has Been Building Stakes In Two Little-Known Stocks
Cathie Wood – the billionaire investor who recently called her flagship fund “the new Nasdaq” has been loading up on shares of the following two small-cap stocks in recent days. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
Via Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday
Via Benzinga
Biotech ETF Tops in June: 5 Stocks That Outperform
Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%. 
Via Talk Markets
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
United Airlines And 3 Other Stocks Insiders Are Buying
Although US stocks closed slightly higher on Monday, there were a few notable insider trades. 
Via Benzinga
74 Biggest Movers From Yesterday
Gainers 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.